Data Events Safety 
NORML
JUNE 18, 2019
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Eight-one percent of subjects reported “at least moderate improvement in their condition … without experiencing serious adverse events.”
NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 4, 2021
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:
Cannabis Law Report
JULY 7, 2021
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
Cannabis Law Report
DECEMBER 7, 2021
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, 1.69, 95% CI [1.20–2.36])
Cannabis Law Report
SEPTEMBER 9, 2021
WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . 20, 2021, from 2:40 – 2:55 p.m.
Cannabis Law Report
SEPTEMBER 15, 2021
The FDA has received adverse event reports involving delta-8 THC-containing products. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g., Adverse events included vomiting, hallucinations, trouble standing, and loss of consciousness. brownies, gummies).
Expert insights. Personalized for you.
279 
Let's personalize your content